Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FLHD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,661
Award facts
- Contract value 100% obligated
- $18,661.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,661.02 to AmerisourceBergen Drug Corp for the supply of Vraylar 3 mg capsules (30-count units) under a firm fixed price contract. This non-set-aside award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Vraylar is a prescription antipsychotic medication used in the treatment of psychiatric conditions, positioning this delivery order within the Defense Logistics Agency's broader pharmaceutical supply chain supporting military and federal healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and established federal contractor, combined with its demonstrated capacity to fulfill competitively awarded contracts across multiple therapeutic domains, positions the company as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FLHD8?
SPE2DB25FLHD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FLHD8 worth?
The government has obligated $18,661 on SPE2DB25FLHD8.
Is contract SPE2DB25FLHD8 an order under another contract?
Yes. SPE2DB25FLHD8 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLHD8 competed?
The extent of competition for SPE2DB25FLHD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award